{"name":"Aminorex","slug":"aminorex","kind":"substance","abbreviations":["AR"],"systematic":null,"aliases":["Apiquel","Aminoxafen","Aminoxaphen","2-Amino-5-phenyl-2-oxazoline","McN-742","2-Oxazolamine, 4,5-dihydro-5-phenyl-","Aminorexum","4,5-Dihydro-5-phenyl-2-oxazolamine","636-641-3","McN 742"],"brands":[],"scraped":true,"has_structure":true,"cid":16630,"classes":[{"name":"stimulant","href":"/class/stimulant"}],"families":[{"name":"phenylethanolamine","href":"/substituted/phenylethanolamine"},{"name":"aminorex","href":"/substituted/aminorex"}],"physical":[{"label":"Molecular mass","value":"162.19 g/mol","copyable":false},{"label":"Appearance","value":"Crystals from benzene","copyable":false},{"label":"Melting point","value":"137 °C","copyable":false},{"label":"Predicted LogP","value":"0.8","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>9</sub>H<sub>10</sub>N<sub>2</sub>O","copyable":true},{"label":"IUPAC name","value":"5-phenyl-4,5-dihydro-1,3-oxazol-2-amine","copyable":true},{"label":"SMILES","value":"C1C(OC(=N1)N)C2=CC=CC=C2","copyable":true},{"label":"InChI","value":"InChI=1S/C9H10N2O/c10-9-11-6-8(12-9)7-4-2-1-3-5-7/h1-5,8H,6H2,(H2,10,11)","copyable":true},{"label":"InChIKey","value":"SYAKTDIEAPMBAL-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"2207-50-3","copyable":true},{"label":"UNII","value":"2SH16612I9","copyable":true},{"label":"PubChem CID","value":"16630","copyable":true}],"pharmacokinetics":[{"label":"Routes of administration","value":"Oral","copyable":false}],"toxicity":[],"dosing":null,"salts":[{"title":"Aminorex fumarate","name":"fumarate","slug":"aminorex_fumarate","drawn":true}],"esters":[],"chirality":"racemic","stereo_type":"enantiomer","optical_activity":"( + / - )","stereoisomers":[{"name":"(R)-Aminorex","href":"/substance/%28r%29-aminorex"},{"name":"(S)-Aminorex","href":"/substance/%28s%29-aminorex"}],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[],"mesh":[],"actives":[],"prodrugs":[],"codrug":false,"interactions":[],"mechanism":"Hypothalamic 5-HT (serotonin) regulates food intake, energy expenditure and bodyweight. Using in vivo microdialysis, /the investigators/ determined the effects of various anorectic drugs on hypothalamic extracellular 5-HT levels during the dark phase when rats predominantly feed. Phentermine and aminorex, which were originally considered to be catecholaminergic drugs, markedly increased 5-HT efflux in rat hypothalamus. Their actions were less profound than D-fenfluramine, but considerably greater than that of the selective 5-HT reuptake inhibitor, fluoxetine. This suggests that enhanced hypothalamic 5-HT function could be involved in their anorectic actions. Pharmacological characterization revealed that D-fenfluramine, aminorex and probably also phentermine potentiate synaptic 5-HT function predominantly by release, whereas fluoxetine acts exclusively by reuptake inhibition. The results also revealed that the combined actions of phentermine and D-fenfluramine on hypothalamic extracellular 5-HT levels were additive, but not synergistic. In contrast, there was a significant negative cooperative effect on extraneuronal 5-HT of combining phentermine with fluoxetine.","side_effects":null,"effects":{"groups":[["Physical Effects",["Abnormal heartbeat","Appetite suppression","Dehydration","Dry mouth","Increased blood pressure","Increased heart rate","Increased libido","Restless legs","Shakiness","Stamina enhancement","Stimulation","Teeth grinding","Vasoconstriction"]],["Cognitive Effects",["Analysis enhancement","Cognitive euphoria","Compulsive redosing","Disinhibition","Ego inflation","Focus enhancement","Increased music appreciation","Mania","Motivation enhancement","Suggestibility suppression","Thought acceleration","Wakefulness"]]]},"usernotes":[],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Brazil","status":"B2","act":null,"refs":[3]},{"jurisdiction":"Canada","status":"Schedule III","act":null,"refs":[]},{"jurisdiction":"United Kingdom","status":"Class C","act":"Misuse of Drugs Act 1971","refs":[]},{"jurisdiction":"United States","status":"Schedule I","act":"Controlled Substances Act","refs":[]},{"jurisdiction":"Germany","status":"Anlage II","act":"Betäubungsmittelgesetz (BtMG)","refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Aminorex"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/16630"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q4064330"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB01490"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL106258"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A134792"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=2207-50-3"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0248332"},{"source":"KEGG","url":"https://www.kegg.jp/entry/D02909"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID00862867"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Aminorex"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/2SH16612I9"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 16630, Aminorex. Accessed November 21, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/16630>https://pubchem.ncbi.nlm.nih.gov/compound/16630</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Aminorex. UNII: 2SH16612I9. Global Substance Registration System. Accessed November 21, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/2SH16612I9>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/2SH16612I9</a>","RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 12:01:57","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 12:01:53","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 12:01:53","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 12:01:54","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 12:01:53","note":"hmdb.ca refused automated access to HMDB0248332"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 12:01:56","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 12:01:51","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 12:01:53","note":"no r/tripreports posts mention it"},{"source":"sider","status":"missing","fetched_at":"2026-11-20 12:01:53","note":"not in SIDER"},{"source":"structure","status":"ok","fetched_at":"2026-11-20 12:01:53","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 12:01:53","note":null}],"description":"Aminorex is a stimulant substance."}